MannKind Corp (NASDAQ:MNKD)
| 3.09 Delayed Data As of 4:02pm ET |  +0.10 / +3.34%Today’s Change | 2.49 Today|||52-Week Range 5.44 | -29.29% Year-to-Date |
Latest MNKD News | Press Releases
No recent news for MannKind Corp.
Today’s Trading
| Previous close | 2.99 |
| Today’s open | 3.00 |
| Day’s range | 3.00 - 3.22 |
| Volume | 113,559 |
| Average volume (3 months) | 5,570,828 |
| Market cap | $792.6M |
Data as of 4:02pm ET, 09/30/2022
Growth & Valuation
| Earnings growth (last year) | -26.24% |
| Earnings growth (this year) | -13.75% |
| Earnings growth (next 5 years) | +30.20% |
| Revenue growth (last year) | +15.81% |
| P/E ratio | NM |
| Price/Sales | 14.44 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TBPHTheravance Biopharma... | +0.05 | +0.49% |
| MIRMMirum Pharmaceutical... | +0.02 | +0.10% |
| AERIAerie Pharmaceutical... | +0.01 | +0.07% |
| VRDNViridian Therapeutic... | +0.62 | +3.11% |
Data as of 4:02pm ET, 09/30/2022
Financials
| Next reporting date | November 8, 2022 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $75.4M |
| Annual profit (last year) | -$80.9M |
| Net profit margin | -107.27% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Danbury, Connecticut |
Forecasts
